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Abstract
We have previously shown that invariant Va19-Ja33 TCR
+ (Va19i T) cells suppress the disease progress in some models for
organ specific autoimmune diseases and type IV allergy that deteriorate along with decline to excess in Th1- or Th17-
immunity. In this study, we examined the effects of over-generation of Va19i T cells on the Th2-controlled immunoglobulin
isotype production in the models for type I allergy. IgE production by invariant Va19-Ja33 TCR transgenic (Tg) mice was
suppressed compared with that by non-Tg controls following administration with goat anti-mouse IgD antiserum or OVA,
while IgG2a production was not influenced by the introduction of the transgene into the recipients. IgE production by wild
type mice was similarly reduced when they were subjected to adoptive transfer with invariant Va19-Ja33 TCR Tg
+ but not
Tg
2 cells prior to immunization. Furthermore, the suppression of IgE production by these recipients was enhanced when
they were previously administered with a Va19i T cell activator, one of the modified a-mannosyl ceramides. In summary, it is
suggested that Va19i T cells have potential to participate in the homeostasis of immunity and that they suppress disease
progression resulting from not only Th1- but also Th2- immunity excess.
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Introduction
The TCR a chain consisting of Va7.2-Ja33 in humans [1] and
Va19-Ja33 (conventionally known as Ja26) in mice [2] is a second
type of invariant TCR a chain first found from blood T cells by
quantitative PCR analyses. This invariant TCR a chain was
preferentially expressed by NK1.1
+ T but not NK1.1
2 T cells in the
livers of CD1
-/- mice where the development of invariant Va14-
Ja18 TCR
+ cells was suppressed [3]. As the invariant Va19-Ja33
TCR is frequently detected in the mucosal-associated lymphoid
tissues such as gut lamina propria, cells expressing the invariant
Va19-Ja33 TCR are often called as mucosal-associated invariant T
(MAIT) cells [4]. Development of invariant Va19-Ja33 TCR
+
(Va19i T) cells is dependent on MHC-related protein 1 (MR1) [4]
which is an evolutionarily conserved MHC-class Ib molecule [5].
They are selected by bone marrow-derived MR1
+ hematopoietic
cells in the thymus and expand in the periphery interacting with the
MR1
+ B cells [6]. Characterization of mice that over-expressed the
invariant Va19-Ja33 TCR a transgene (Tg) via a natural TCR a
promoter revealed that invariant Va19-Ja33 TCR Tg
+ cells are
distributed to not only gut lamina propria but also the lymphoid
organs including the liver of the Tg mice [7–9].
Va19i T cells produce immunoregulatory cytokines in response
to TCR engagement [7–10]. Va19i cells show either Th1- or Th2-
biased profiles of immunoregulatory cytokine production depend-
ing on the duration and intensity of TCR stimulation in vitro [10],
suggesting their involvement in the regulation of the immune
system. In fact, NK1.1
+ Va19i T cells induced IL-10 production
from B cells and suppressed the disease progress of experimental
autoimmune encephalomyelitis, an animal model of multiple
sclerosis [11]. Furthermore, we have recently found that onset of
diabetes in NOD mice and induction of delayed-type hypersen-
sitivity toward sheep erythrocytes in mice are suppressed by the
over-expression of invariant Va19-Ja33 TCR a Tg in the subjects
[12]. In this study, the effects of the over-generation of Va19i T
cells on disease progress in the models for type I allergy were
explored to elucidate their immunoregulatory potential.
Materials and Methods
Mice
C57BL/6 mice were purchased from Sankyo Service Co.
(Tokyo, Japan). CD1-deficient mice were provided by Dr. M.J.
Grusby (Harvard University) [13]. They were backcrossed with
C57BL/6 mice 6 times, and mice with the phenotypes H-2
b,
NK1.1
+, and CD1
-/- were selected. TCR Ca-deficient mice, that
had been backcrossed with C57BL/6 mice for more than 10
generations [14], were donated by Drs. H. Ishikawa (Keio
University) and M. Nanno (Yakult Co.). Invariant Va19-Ja33
TCR transgene cloned from a hybrid line (NB 403, [3]) was linked
with TCR a promoter and enhancer and transgenic mouse lines
with C57/BL/6, TCR a
-/- and CD1
-/- genetic backgrounds were
established as described previously [9]. All the experiments using
mice have been done with the approval of the animal experiment
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approval No. 105 in 2008).
Cell preparations
Mononuclear cells (MNC) were prepared from mouse organs by
density gradient centrifugation using Lymphosepar II (IBL,
Gunma, Japan, d=1.090) for spleen cells or Percoll (Pharmacia,
Uppsala, Sweden) for liver cells as described previously [15].
Administration of mice with allergens and determination
of serum immunoglobulin
Mice (8,12 weeks of age) were intraperitoneally injected with
200 ml of goat anti-mouse IgD antiserum (obtained from Dr. F.
Finkelman, University of Cincinnati Medical Center). In other
experiments, mice were injected with 100 mg of ovalbumin (OVA)
(Sigma) emulsified in complete Freund’ s adjuvant followed by
100 mg of OVA in incomplete Freund’ s adjuvant after 2 weeks.
In some cases, C57BL/6 mice were subjected to adoptive transfer
of liver MNCs prepared from Va19Tg
+TCR a
-/- or C57BL/6
mice (1610
7/animal), and after three days these mice were used as
recipients. The serum levels of immunoglobulin isotypes and
cytokines were determined by ELISA using specific antibodies
obtained from BD Bioscience (Pharmingen, San Diego, US).
OVA-specific immunoglobulin isotypes were determined as
previously reported by Zhang et al. [16]. Pooled serum of OVA-
immunized C57BL/6 mice was used as a standard and assigned
values of OVA-specific IgE, IgG1 and IgG2a of 10 U/ml,
2000 U/ml and 10 U/ml, respectively.
Cell culture
Mice were immunized with OVA as described above. Spleen
MNCs were prepared from them 5 weeks after initial immuniza-
tion with OVA. They were cultured at the concentration of
5610
6 /ml in DMEM containing 10% FCS, 50 mg/ml strepto-
mycin, 50 U/ml penicillin in the presence or absence of OVA
(100 mg/ml). Immunoglobulin isotypes and cytokines in the
culture supernatants were determined by ELISA on 1 and 3 day
of culture.
Glycolipids
N-[1-(a-mannosyl oxymethyl)-3-(4-octyl-phenyl) propyl] hexa-
decanamide (a-ManCer4Ph) prepared as described previously [17]
was provided by Dr. Tadashi Mishina (Mitsubishi Pharma Co.). a-
ManCer4Ph was dissolved with DMSO (10 mg/ml). The stock
solution was diluted with PBS (x200), sonicated and injected into
mice (25 mg/animal) in some experiments.
Statistical analysis
Data are shown as the mean 6s.d. The significance of diffe-
rences was determined by the Student’s t-test.
Results
Serum immunoglobulin levels in Va19 Tg mice
We have shown that Va19i T cells have potential to produce
different kind of immunoregulatory cytokines in response to TCR
engagement and that over-generation of Va19i cells T suppress
the disease progress in the models where disease becomes serious
with excess in Th1 or Th17 immunity. In this study we examined
the possible involvement of Va19i T cells in the control of serum
immunoglobulin isotype levels in animal models for type I allergy.
The basal levels of several immunoglobulin isotypes in serum
were measured in invariant Va19-Ja33 Tg mice and compared
with those in non-Tg mice with the same genetic background
(Figure 1). The levels of the Th2-controlled immunoglobulin
isotypes (IgE, IgG1) in the Va19 Tg mice were raised, whereas the
levels of Th1-controlled 1gG2a in the Tg mice tended to decrease.
A superiority of Th2-controlled isotype production was found in
the Va19-Ja33 Tg mice of independently established lines (line 12,
26 and 28, C57BL/6 background) in common in comparison with
their non-Tg litter mates. The serum IgE level of Va19 Tg
+ mice
was similarly higher than that of non-Tg mice from the same litter
with the CD1
-/- genetic background where invariant Va14 NKT
cell development is suppressed. Thus, Va19i T cells are suggested
to contribute to the maintenance of Th1/Th2 homeostasis in a
state that is biased toward Th2 under the physiological conditions.
Immunoglobulin production by Va19 Tg mice after
injection with a polyclonal immune activator
Immunoglobulin production by Va19 Tg mice was compared
with the production by non-Tg mice after administration with a
polyclonal immune activator goat anti-mouse IgD antiserum
(Figure 2A). Interestingly, the rise in the serum IgE level in the
Va19 Tg
+ mice was significantly suppressed (690063800 ng/ml)
compared with that in non-Tg mice with the same genetic
background (C57BL/6) (1730064300 ng/ml). Similarly, the rise
in the serum IgG1 level in the Tg mice (1900064000 mg/ml) was
less that that in the non-Tg mice (2600066000 mg/ml). Since the
rise in IgG2a in the Tg mice (730670 mg/ml) was comparable to
the rise in the non-Tg mice (6806150 mg/ml), the suppressed
production of Th2 immunoglobulin isotypes (IgE, IgG1) in the Tg
mice may be due to the over-generated Va19i T cells but not to
the restriction of the generation of helper T cell repertoires.
To address this issue we compared immunoglobulin production
by wild type mice previously subjected to adoptive transfer with
lymphocytes prepared from either Va19 TCR Tg
+ or non-Tg
mice (Figure 2B). Serum IgE levels in the mice subjected to
transfer with the Tg
+ cells were lower than the levels in the mice
subjected to transfer with the non-Tg cells. Thus, these results
further support the notion that the suppressed production of Th2
immunoglobulin isotypes in the Tg mice is caused by the functions
of Va19i T cells rather than by the artificial effects accompanied
with the transgene expression.
Immunoglobulin production by Va19 Tg mice after
immunization with OVA
Next, antigen-specific immunoglobulin production by Va19
Tg
+ and non-Tg mice was compared. Mice were immunized with
OVA and the serum levels of OVA-specific immunoglobulin
isotypes were determined. OVA-specific IgE level in the serum
of the Va19 Tg mice was lower than that in non-Tg mice with
the same background (C57BL/6); whereas, the OVA-specific
IgG2a level was comparable between the Tg and non-Tg mice
(Figure 3A). Similarly, serum IgE and IgG1 levels in the wild type
mice previously subjected to transfer with the Tg
+ cells were lower
than the levels in the mice subjected to transfer with the non-Tg
cells, while serum IgG2a levels in the mice injected with Tg
+ and
non-Tg cells were comparable (Figure 4A).
Less production of Th2 controlled immunoglobulin isotypes in
the OVA-immunized mice with over-generation of Va19i T cells
was also suggested from analysis of the cells isolated from those
mice in vitro. The splenocytes prepared from OVA-immunized
mice were moved to culture and immunoglobulin isotypes and
cytokines in the culture supernatants were determined (Figure 3B,
4B). Production of IgE and IgG1 by the splenocytes from the Tg
+
mice (Figure 3B) or the Tg
2 mice transferred with Tg
+ cells
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mice or non-Tg mice transferred with non-Tg cells, while IgG2a
production was comparable between the cells of Tg
+ and Tg
2
mice. Interestingly, the splenocytes isolated from the Tg
+ mice or
the Tg
2 mice transferred with Tg
+ cells produced more IFN-c and
IL-17 than the splenocytes from the non-Tg mice or the non-Tg
mice transferred with non-Tg cells. In contrast IL-4 production by
the splenocytes of each origin was comparable. Presumably, Va19i
T cells over-generated in the Tg mice participated in the increased
production of IFN-c and IL-17 and eventually brought about the
less production of the Th2-controlled immunoglobulin isotypes.
Collectively, these findings suggest that Va19i T cells contri-
bute to the homeostasis of the Th1/Th2 balance in the mice
immunized with antigens capable of inducing type I allergy.
Effects of administration of Va19i T cell activators on the
immunoglobulin isotype production
We have previously reported that Va19i T cells are specifically
activated with certain a-mannosyl glycolipids in the context of
MR1 [18,19]. A derivative of a-ManCer (a-ManCer4Ph) has
potential to induce immunoregulatory cytokine production from
Va19i T cells not only in culture but also in vivo [18]. We
examined the effects of this glycolipid on the immunoglobulin
isotype production.Invariant TCR a Tg
+ or Tg
2 mice with
CD1
-/- genetic background were injected with a-ManCer4Ph
concomitantly with goat anti-mouse IgD antiserum, and immu-
noglobulin isotypes in the serum were determined (Figure 5A).
IgE and IgG1 but not IgG2a production was reduced in the Tg
+
mice and the reduction was enhanced with the a-ManCer4Ph
Figure 1. Immunoglobulin isotype levels in the serum of Va19-Ja33 TCR a (Va19 ) Tg and non-Tg mice. Serum IgE, IgG1 and IgG2a levels
of invariant Va19 Tg of independently established Tg lines (Line 12, 26, 28) were compared with those of non-Tg mice the same genetic background
(C57BL/6 or CD1
-/-). Each circle represents the immunoglobulin level of an individual mouse (2–3 months-old). The mean levels of each isotype are
shown with bars. P values in the Student’ s t-test are indicated in the panels.
doi:10.1371/journal.pone.0020915.g001
Modulation of IgE Production by Va19i T Cells
PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e20915administration. Next, invariant TCR a Tg
2 mice subjected to
adoptive transfer with either invariant Va19 TCR Tg
+ or
Tg
2 cells were injected with a-ManCer4Ph concomitantly with
immunization with OVA (at 0 and 2 week), and OVA-specific
immunoglobulin isotypes in the serum were determined (Figure 5B).
The reduction in the Th2 controlled immunoglobulin isotype
production was similarly observed in the Tg
2 mice transferred with
Tg
+ but not with Tg
2 cells when the mice were injected with
a-ManCer4Ph. Thus, Va19i T cells activated with a-ManCer4Ph
are likely to work as a regulator of immunoglobulin isotype
production.
Discussion
We have previously found that Va19i T cells promptly produce
immunoregulatory cytokines upon invariant TCR engagement
and that the cytokine spectra are altered according to the inten-
sity and the duration of stimulation to invariant TCR [10]. We
speculate that the regulatory functions of Va19i T cells arise from
their potential to produce either Th1 or Th2 -dominant cytokines
according to the circumstances.
The serum levels of Th2-controlled immunoglobulin isotypes (IgE
and IgG1)inthe invariant Va19-Ja33TCRTgmicearehigherthan
those in the non-Tg mice (Figure 1). Va19i T cells are thus suggested
to induce somewhat Th2-biased immunity under the physiological
conditions (without administration of antigens). In accordance with
this observation, we have previously found the suppressed
progression of diseases in the models for organ specific inflammatory
autoimmunity [11,12] and T cell mediated type IV allergy [12]
where excess in Th1 immunity tends to worsen the disease.
On the contrary, the production of IgE, and to some extent
IgG1, following administration of allergens was suppressed in the
invariant Va19-Ja33 TCR Tg mice when compared with the
production in the non-Tg mice (Figure 2, 3). It is thus supposed
that Va19i T cells over-generated in the Tg mice lessened the
excess in Th2 immunity with exposure to allergens. The increased
production of IL-17 and IFN-c in culture by the spleen cells of
the OVA-immunized Tg
+ mice or non-Tg mice transferred
with invariant Va19-Ja33 TCR Tg
+ cells may account for the
restoration from the Th2 excess in those mice (Figure 3B, 4B).
Interestingly, negative regulation of established allergic asthma by
IL-17 has been suggested in a recent report [20]. Recently Va19i
Figure 2. Immunoglobulin isotype levels in the serum of Va19 Tg and non-Tg mice before and after administration with goat anti-
mouse IgD antiserum. (A) Va19 Tg and non-Tg mice (C57BL/6 genetic background) were injected with a polyclonal immune activator (goat anti-
mouse IgD antiserum). Immunoglobulin isotype levels in the serum before and after immunization (1 w) were determined by ELISA. (B) C57BL/6 mice
were subjected to adoptive transfer with liver MNCs prepared from either V 19 Tg+ TCR -/- or non-Tg (C57BL/6) mice. After 3 days these mice were
immunized with goat anti-mouse IgD antiserum. Serum IgE levels were determined after 1 w. The mean levels are shown with bars.
doi:10.1371/journal.pone.0020915.g002
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+ and non-Tg mice after immunization with OVA. (A)
Va19Tg and non-Tg mice (C57BL/6 genetic background) were immunized with OVA (at week 0 and 2) as described in Materials and Methods, and
OVA-specific immunoglobulin levels in the serum were determined every week by ELISA. The mean 6 s.d. of five mice from each strain is shown.
Experiments were repeated twice, and essentially similar results were obtained. (B) Immunoglobulin and cytokine production by spleen cells in vitro
prepared from OVA-immunized mice. Va19 Tg
+ and non-Tg mice were immunized with OVA as shown in (A), and spleen MNCs were prepared from
each mouse 5 weeks after initial immunization. The cells were cultured in the presence or absence of OVA, and immunoglobulin isotypes and
cytokines in the culture supernatants were determined by ELISA on 1 and 3 day of culture. Mean values of four mice in each group are shown.
doi:10.1371/journal.pone.0020915.g003
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+ cells.
(A) C57BL/6 mice transferred with liver MNCs isolated from either Va19 Tg
+ TCR a
-/- or C57BL/6 mice were immunized with OVA as described in
Figure 3 and the serum levels of OVA-specific immunoglobulin were determined by ELISA. The mean values obtained from five mice are shown. (B)
Immunoglobulin and cytokine production by spleen cells in vitro prepared from OVA-immunized mice. C57BL/6 mice were injected with either Va19
Tg or non-Tg liver MNCs, and then immunized with OVA as described in (A). Spleen MNCs were prepared from each mouse 5 weeks after initial
immunization and the cells were cultured in the presence or absence of OVA. After 1 and 3 day of culture, immunoglobulin isotypes and cytokines in
the culture supernatants were determined by ELISA. Mean values of five mice in each group are shown.
doi:10.1371/journal.pone.0020915.g004
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microbial infection [21,22]. These cells possibly contribute to the
induction of Th1 or Th17 immunity against invading microbes.
The potential of Va19i T cells underlying the exclusion of
microbes and the restoration from the excess in Th2 immunity
during exposure to allergens may be partially in common.
In the present study Va19i T cells are suggested to have the
capacity to contribute to the homeostasis of Th1 and Th2
immunity. However, it is not clearly understood yet how Va19i T
cells regulate the immune system. Presumably, the affinity of the
antigen/MR1 complex to invariant Va19 TCR definitively
influences the pattern of immunoregulatory cytokine production
by Va19i T cells judging from our previous observations that the
profiles of cytokines are dependent on how invariant Va19 TCR is
stimulated in vitro [10]. It may be possible to speculate that Va19i
T cells are induced to produce a slight amount of Th2-dominant
cytokines continuously by relatively weak stimulation to the
invariant TCR with certain self or foreign antigens when the
hosts are under the physiological conditions. On the other hand,
invasion of certain foreign pathogens or allergens may induce the
hosts to generate putative MR1-coupled antigens with high affi-
nity to invariant Va19 TCR that are capable of inducing Th1
or Th17-dominant cytokine production from Va19i T cells. The
cytokines secreted by Va19i T cells may contribute to the
induction of Th1 or Th17 immunity and have crucial roles in the
suppression of Th2-controlled immunoglobulin production.
It is interesting that the serum levels of Th2-controlled immu-
noglobulin isotypes in the invariant Va14-Ja18 TCR Tg mice are
similarly higher than those in the non-Tg mice [23,24]. Taking
into account the report that human invariant Va24-Ja18 TCR
+
cells produce altered immunoregulatory cytokines depending on
the way of TCR engagement [25], Va14 NKT cells are also conti-
nuously stimulated with certain self or foreign antigens thereby
induced to produce Th2-biased cytokines under the physiological
conditions. The elevated serum levels of Th2-controlled immuno-
globulin isotypes found in such invariant TCR a Tg mice are
probably due to the immunoregulatory functions of Va19i T
or Va14 NKT cells, since the serum IgE levels in irrelevant TCR
a (Va8-Ja37) Tg mice are comparable to those in the non-Tg
mice [25].
Figure 5. Effects of glycolipid administration on the immunoglobulin production. (A) Va19 Tg
+ or Tg
2 mice with CD1
-/- genetic
background were injected with goat anti-mouse IgD antiserum. A Va19i T cell activator a-ManCer4Ph was intravenously injected concomitantly with
the antigen into a group of mice. Serum levels of immunoglobulin isotypes were determined on day 6, 8 and 10 day by ELISA. Mean values of three
mice in each group are shown. (B) C57BL/6 mice subjected to adoptive transfer with liver MNCs from either Va19 Tg
+ TCR a
-/- or C57BL/6 mice were
immunized with OVA as shown in Figure 4. A Va19i cell activator a-ManCer4Ph was intravenously injected concomitantly with OVA into a group of
mice (at 0 and 2 w). Serum levels of OVA-specific immunoglobulin isotype were determined after 3, 4 and 5 week by ELISA. Mean values of five mice
in each group are shown.
doi:10.1371/journal.pone.0020915.g005
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Th2-controlled immunoglobulin production in non-primed mice
is suggested, the regulatory function by Va14 NKT cell in mice
exposed to allergens is controversial. For instance, Cui et al.
reported that serum IgE levels in Ja18
-/- mice were comparable to
those in wild type mice following OVA immunization [26],
whereas Akbari et al. demonstrated the reduction in the OVA-
specific IgE production by Ja18
-/- or CD1
-/- mice compared with
the wild type controls [27]. However, it is likely that the
suppression of Th2-controlled immunoglobulin production ob-
served in the invariant Va19 Tg mice upon exposure to allergens
is substantially attributable to Va19i T cells because the suppre-
ssion was observed even in the Va19 Tg mice with CD1-deficient
genetic background and was enhanced with a-ManCer4Ph admi-
nistration (Figure 5A).
So far, a synthetic glycolipid a-ManCer4Ph has been demon-
strated to induce production of IFN-c and IL-17 from Va19i T
cells in an MR1-dependent manner in vitro and in vivo more
intensively than the others, although this glycolipid also has poten-
tial to induce production of IL-4 to a degree [18]. We speculate
that a-ManCer4Ph might partially mimic the roles of putative
natural ligands for MR1-restricted Va19i T cells. Administration
of a-ManCer4Ph has been shown to suppress Th2-controlled
immunoglobulin production in the Tg
+ mice and non-Tg mice
transferred with Va19 TCR Tg
+ cells following antigen immuni-
zation (Figure 5). Thus Va19i T cells under the MR1-restriction
are likely to take important roles in the regulation of immuno-
globulin production. However, MR1-restriction of the regulatory
functions by Va19i T cells should be formally verified by the
examination of immunoglobulin production by Va19 Tg
+ mice
under the MR1
+ and MR1
2 conditions.
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